Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Published Online
on April 14, 2003

Circulation. 2003
Published online before print April 14, 2003, doi: 10.1161/01.CIR.0000065220.70220.F7
A more recent version of this article appeared on April 29, 2003
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
107/16/2102    most recent
01.CIR.0000065220.70220.F7v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, C.-H.
Right arrow Articles by Yang, C.-Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, C.-H.
Right arrow Articles by Yang, C.-Y.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CALCIUM COMPOUNDS
*CALCIUM, ELEMENTAL
Medline Plus Health Information
*Cholesterol
Related Collections
Right arrow Apoptosis
Right arrow Gene expression
Right arrow Gene regulation
Right arrow Growth factors/cytokines
Right arrow Lipid and lipoprotein metabolism

Submitted on December 19, 2002
Accepted on February 10, 2003

Low-Density Lipoprotein in Hypercholesterolemic Human Plasma Induces Vascular Endothelial Cell Apoptosis by Inhibiting Fibroblast Growth Factor 2 Transcription

Chu-Huang Chen MD, PhD*, Tao Jiang PhD, Jun-Hai Yang PhD, Wei Jiang MD, Jonathan Lu MD, Gopal K. Marathe PhD, Henry J. Pownall PhD, Christie M. Ballantyne MD, Thomas M. McIntyre PhD, Philip D. Henry MD, and Chao-Yuh Yang PhD

From the Departments of Medicine (C.-H.C., T.J., W.J., J.L., H.J.P., C.M.B., P.D.H., C.-Y.Y.) and Ophthalmology (J.-H.Y.), Baylor College of Medicine, Houston, Tex, and the Department of Internal Medicine (G.K.M., T.M.M.), University of Utah, Salt Lake City.

* To whom correspondence should be addressed. E-mail: cchen{at}bcm.tmc.edu.

Background--Apoptosis of vascular endothelial cells (ECs) can be induced in vitro by experimentally modified LDL. Description of proapoptotic circulating lipoproteins may significantly enhance understanding of atherothrombosis pathophysiology.

Methods and Results--Fast protein liquid chromatography of LDL samples from 7 asymptomatic, hypercholesterolemic patients yielded subfractions L1-L5 in increasing electronegativity. L4 and L5 were not detectable or collectible in normolipidemic samples. In bovine aortic EC cultures, L5 induced marked apoptosis and L4 had a mild effect, whereas hypercholesterolemic or normolipidemic L1-L3 had negligible effects. Compared with copper-oxidized LDL, L5 was only mildly oxidized, although its propensity to form conjugated dienes in response to copper exceeded that of other subfractions. L5-induced apoptosis was associated with suppressed fibroblast growth factor 2 (FGF-2) transcription, as assessed by nuclear run-on analysis. Degrading platelet-activating factor (PAF)-like lipids in L5 by a recombinant PAF acetylhydrolase prevented both FGF-2 downregulation and apoptosis. Furthermore, the ability of L5 lipid extract to induce calcium influx into neutrophils was lost after pretreatment of the extract with PAF acetylhydrolase. FGF-2 supplementation, PAF receptor (PAFR) blockade with WEB-2086, and inactivation of PAFR-coupled Gi protein with pertussis toxin all effectively attenuated L5-induced apoptosis.

Conclusions--Our findings indicate that a highly electronegative, mildly oxidized LDL subfraction present in human hypercholesterolemic but not normolipidemic plasma can induce apoptosis in cultured ECs. The evidence that a freshly isolated LDL species modulates transcription of FGF-2 may provide a physiological insight into the mechanism of vascular EC apoptosis in hypercholesterolemia.


Key words: lipoproteins • endothelium • apoptosis • growth substances • phospholipids




This article has been cited by other articles:


Home page
Circ. Res.Home page
J. L. Kielczewski, Y. P.R. Jarajapu, E. L. McFarland, J. Cai, A. Afzal, S. Li Calzi, K. H. Chang, T. Lydic, L. C. Shaw, J. Busik, et al.
Insulin-Like Growth Factor Binding Protein-3 Mediates Vascular Repair by Enhancing Nitric Oxide Generation
Circ. Res., October 23, 2009; 105(9): 897 - 905.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
C.-H. Chen, R. A.F. Dixon, L.-Y. Ke, and J. T. Willerson
Vascular Progenitor Cells in Diabetes Mellitus: Roles of Wnt Signaling and Negatively Charged Low-Density Lipoprotein
Circ. Res., May 8, 2009; 104(9): 1038 - 1040.
[Full Text] [PDF]


Home page
Circ. Res.Home page
J. Lu, J.-H. Yang, A. R. Burns, H.-H. Chen, D. Tang, J. P. Walterscheid, S. Suzuki, C.-Y. Yang, T. Sawamura, and C.-H. Chen
Mediation of Electronegative Low-Density Lipoprotein Signaling by LOX-1: A Possible Mechanism of Endothelial Apoptosis
Circ. Res., March 13, 2009; 104(5): 619 - 627.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
C. Bancells, S. Benitez, M. Jauhiainen, J. Ordonez-Llanos, P. T. Kovanen, S. Villegas, J. L. Sanchez-Quesada, and K. Oorni
High binding affinity of electronegative LDL to human aortic proteoglycans depends on its aggregation level
J. Lipid Res., March 1, 2009; 50(3): 446 - 455.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
M. Pirro, G. Schillaci, P. F. Romagno, M. R. Mannarino, F. Bagaglia, R. Razzi, L. Pasqualini, G. Vaudo, and E. Mannarino
Influence of Short-term Rosuvastatin Therapy on Endothelial Progenitor Cells and Endothelial Function
Journal of Cardiovascular Pharmacology and Therapeutics, March 1, 2009; 14(1): 14 - 21.
[Abstract] [PDF]


Home page
Ther Adv Cardiovasc DisHome page
M. Pirro, F. Bagaglia, L. Paoletti, R. Razzi, and M. R. Mannarino
Review: Hypercholesterolemia-associated endothelial progenitor cell dysfunction
Therapeutic Advances in Cardiovascular Disease, October 1, 2008; 2(5): 329 - 339.
[Abstract] [PDF]


Home page
Circ. Res.Home page
M. A. Medina
Hyperhomocysteinemia and Occlusive Vascular Disease: An Emergent Role for Fibroblast Growth Factor 2
Circ. Res., April 25, 2008; 102(8): 869 - 870.
[Full Text] [PDF]


Home page
Circ. Res.Home page
P.-Y. Chang, S.-C. Lu, C.-M. Lee, Y.-J. Chen, T. A. Dugan, W.-H. Huang, S.-F. Chang, W. S.L. Liao, C.-H. Chen, and Y.-T. Lee
Homocysteine Inhibits Arterial Endothelial Cell Growth Through Transcriptional Downregulation of Fibroblast Growth Factor-2 Involving G Protein and DNA Methylation
Circ. Res., April 25, 2008; 102(8): 933 - 941.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
D. Tang, J. Lu, J. P. Walterscheid, H.-H. Chen, D. A. Engler, T. Sawamura, P.-Y. Chang, H. J. Safi, C.-Y. Yang, and C.-H. Chen
Electronegative LDL circulating in smokers impairs endothelial progenitor cell differentiation by inhibiting Akt phosphorylation via LOX-1
J. Lipid Res., January 1, 2008; 49(1): 33 - 47.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
J. Lu, W. Jiang, J.-H. Yang, P.-Y. Chang, J. P. Walterscheid, H.-H. Chen, M. Marcelli, D. Tang, Y.-T. Lee, W. S.L. Liao, et al.
Electronegative LDL Impairs Vascular Endothelial Cell Integrity in Diabetes by Disrupting Fibroblast Growth Factor 2 (FGF2) Autoregulation
Diabetes, January 1, 2008; 57(1): 158 - 166.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. Cheng, R. Cui, C.-H. Chen, and J. Du
Oxidized Low-Density Lipoprotein Stimulates p53-Dependent Activation of Proapoptotic Bax Leading to Apoptosis of Differentiated Endothelial Progenitor Cells
Endocrinology, May 1, 2007; 148(5): 2085 - 2094.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
C.-H. Chen and J. P. Walterscheid
Plaque Angiogenesis Versus Compensatory Arteriogenesis in Atherosclerosis
Circ. Res., October 13, 2006; 99(8): 787 - 789.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. K. Marathe, C. Johnson, S. D. Billings, M. D. Southall, Y. Pei, D. Spandau, R. C. Murphy, G. A. Zimmerman, T. M. McIntyre, and J. B. Travers
Ultraviolet B Radiation Generates Platelet-activating Factor-like Phospholipids underlying Cutaneous Damage
J. Biol. Chem., October 21, 2005; 280(42): 35448 - 35457.
[Abstract] [Full Text] [PDF]


Home page
Annals of Clinical & Laboratory ScienceHome page
J. W. Choi and S. K. Kim
Relationships of Soluble APO-1 (Fas/CD95) Concentrations, Obesity, and Serum Lipid Parameters in Healthy Adults
Ann. Clin. Lab. Sci., January 1, 2005; 35(3): 290 - 296.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. Bonin, S. D. Ryan, L. Migahed, F. Mo, J. Lallier, D. J. Franks, H. Arai, and S. A. L. Bennett
Anti-apoptotic Actions of the Platelet-activating Factor Acetylhydrolase I {alpha}2 Catalytic Subunit
J. Biol. Chem., December 10, 2004; 279(50): 52425 - 52436.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
P.-Y. Chang, S.-C. Lu, T.-C. Su, S.-F. Chou, W.-H. Huang, J. D. Morrisett, C.-H. Chen, C.-S. Liau, and Y.-T. Lee
Lipoprotein-X reduces LDL atherogenicity in primary biliary cirrhosis by preventing LDL oxidation
J. Lipid Res., November 1, 2004; 45(11): 2116 - 2122.
[Abstract] [Full Text] [PDF]